This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects

Clinical trial NCT07304791 · RECRUITING

Trial details

NCT number: NCT07304791
Sponsor: Beam Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Healthy Participant Study

Start date: 2025-10-27
Primary completion: 2026-01-29
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.